Company:  RADNET, INC. (RDNT)
Form Type:  10-K
Filing Date:  3/18/2019 
CIK:  0000790526 
Address:  1510 COTNER AVE. 
City, State, Zip:  LOS ANGELES, California 90025 
Telephone:  310-478-7808 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$17.89  
Change: 
0.31 (1.76%)  
Trade Time: 
10:27 AM EST  
Market Cap: 
$899.36M
Trade RDNT now with 

© 2019  
Description of Business
We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue. At December 31, 2018, we operated directly or indirectly through joint ventures with hospitals, 344 centers located in California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
    Licensing and Certification Laws
    Item 1A. Risk Factors
    Item 1B. Unresolved Staff Comments
    PART I
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Mine Safety Disclosures
    PART II
      Item 5. Market for the Registrant's Common Equity, Related ...
      Item 6. Selected Consolidated Financial Data
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
        Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      NOTE 11 - STOCK-BASED COMPENSATION
        NOTE 15 - SUBSEQUENT EVENTS
      Item 9A Controls and Procedures
      Report of Independent Registered Public Accounting Firm
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 13. Certain Relationships and Related Transactions, ...
      Item 14. Principal Accountant Fees and Services
    PART IV
      Item 15. Exhibits and Financial Statements Schedule
    VALUATION AND QUALIFYING ACCOUNTS
    SIGNATURES
  EXHIBIT 10.28
  EXHIBIT 10.29
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO